Healthy Clinical Trial
Official title:
The Positive Effects of an Urban Afforestation Activity on the Mental Health of Adults
| NCT number | NCT05362552 |
| Other study ID # | AfforestAffect |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 9, 2022 |
| Est. completion date | May 20, 2022 |
| Verified date | May 2022 |
| Source | Universidad de Granada |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on affect and vitality levels in a sample of young adults.
| Status | Completed |
| Enrollment | 152 |
| Est. completion date | May 20, 2022 |
| Est. primary completion date | May 20, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Adults between 18 and 65 years. - Any sex and gender. Exclusion Criteria: - Intake of any psychotropic medication. - Other severe or medically unstable diseases that may interfere with participation. - Severe cognitive impairment (Mini-Mental State Examination score < 17 out of 30 points). - Severe mental disorders in the acute phase or symptomatic phase. - Severe intellectual disability. - Behavioural alterations as this may interfere with their participation. |
| Country | Name | City | State |
|---|---|---|---|
| Spain | University of Granada, Faculty of Health Sciences | Granada |
| Lead Sponsor | Collaborator |
|---|---|
| Universidad de Granada |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Affect | The Spanish adaptation of the Positive and Negative Affect Schedule will be utilised. Participants rate how they feel at the present moment on a five-point Likert scale, where "not at all or very slightly" is scored as 1 and "a lot" as 5. Scores of two 10-item subscales will be analysed separately in the analysis, labelled either as Positive Affect or Negative Affect. Higher scores in the Positive Affect subscale represent higher levels of positive affect and lower scores in the Negative Affect subscale represent lower levels of negative affect. | Change from baseline affect after 90 minutes. | |
| Primary | Subjective Vitality | The 6-item Spanish adaptation of the Subjective Vitality Scale will be utilised. Participants will transmit their levels of energy and aliveness at the present moment by rating the items on a seven-point Likert scale where 1 stands for "Not true at all" and 7 "Very true". The scores for each item will be summed up for statistical analyses. Higher scores indicate higher levels of energy and aliveness feeling. | Change from baseline subjective vitality after 90 minutes. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |